Thromb Haemost 1995; 74(03): 997
DOI: 10.1055/s-0038-1649867
Letter to the Editor
Schattauer GmbH Stuttgart

Risk of Inhibitor Development after Intermediate Purity Coagulation Factor Concentrates: Is It Truly Low?

P M Mannucci
Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center, Institute of Internal Medicine, University of Milan, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 10. Mai 1995

Accepted 22. Mai 1995

Publikationsdatum:
09. Juli 2018 (online)